Considering the ‘Alternatives’ for Next-Generation Anti-Staphylococcus aureus Vaccine Development
Staphylococcus aureus is an opportunistic pathogen, which can readily develop antibiotic resistance and result in severe disease. To combat antibiotic resistance, new treatment strategies are being developed with a particular focus on vaccine development. S. aureus vaccines that target humoral immun...
Ausführliche Beschreibung
Autor*in: |
O’Brien, Eóin C. [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2019transfer abstract |
---|
Schlagwörter: |
---|
Umfang: |
14 |
---|
Übergeordnetes Werk: |
Enthalten in: Ocean sand ridge signatures in the Bohai Sea observed by satellite ocean color and synthetic aperture radar measurements - 2011transfer abstract, Amsterdam [u.a.] |
---|---|
Übergeordnetes Werk: |
volume:25 ; year:2019 ; number:3 ; pages:171-184 ; extent:14 |
Links: |
---|
DOI / URN: |
10.1016/j.molmed.2018.12.010 |
---|
Katalog-ID: |
ELV045954380 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV045954380 | ||
003 | DE-627 | ||
005 | 20230626012736.0 | ||
007 | cr uuu---uuuuu | ||
008 | 191021s2019 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.molmed.2018.12.010 |2 doi | |
028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000896.pica |
035 | |a (DE-627)ELV045954380 | ||
035 | |a (ELSEVIER)S1471-4914(19)30002-4 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 050 |q VZ |
082 | 0 | 4 | |a 550 |q VZ |
082 | 0 | 4 | |a 660 |q VZ |
082 | 0 | 4 | |a 660 |q VZ |
082 | 0 | 4 | |a 530 |a 600 |a 670 |q VZ |
084 | |a 51.00 |2 bkl | ||
100 | 1 | |a O’Brien, Eóin C. |e verfasserin |4 aut | |
245 | 1 | 0 | |a Considering the ‘Alternatives’ for Next-Generation Anti-Staphylococcus aureus Vaccine Development |
264 | 1 | |c 2019transfer abstract | |
300 | |a 14 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a Staphylococcus aureus is an opportunistic pathogen, which can readily develop antibiotic resistance and result in severe disease. To combat antibiotic resistance, new treatment strategies are being developed with a particular focus on vaccine development. S. aureus vaccines that target humoral immunity alone do not provide sufficient protection from all disease phenotypes associated with this pathogen. Recent studies have identified the requirement for cellular immunity to provide a robust immune response to this infection. Driving conventional T cell responses has therefore become the focus of intense research in this area. Recently described ‘alternative’ T cells could provide a novel strategy for improving therapeutic efficacy and success in next-generation anti-S. aureus vaccine design. | ||
520 | |a Staphylococcus aureus is an opportunistic pathogen, which can readily develop antibiotic resistance and result in severe disease. To combat antibiotic resistance, new treatment strategies are being developed with a particular focus on vaccine development. S. aureus vaccines that target humoral immunity alone do not provide sufficient protection from all disease phenotypes associated with this pathogen. Recent studies have identified the requirement for cellular immunity to provide a robust immune response to this infection. Driving conventional T cell responses has therefore become the focus of intense research in this area. Recently described ‘alternative’ T cells could provide a novel strategy for improving therapeutic efficacy and success in next-generation anti-S. aureus vaccine design. | ||
650 | 7 | |a MAIT cells |2 Elsevier | |
650 | 7 | |a γδ cells |2 Elsevier | |
650 | 7 | |a innate lymphoid cells |2 Elsevier | |
650 | 7 | |a Staphylococcus aureus |2 Elsevier | |
700 | 1 | |a McLoughlin, Rachel M. |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Elsevier Science |t Ocean sand ridge signatures in the Bohai Sea observed by satellite ocean color and synthetic aperture radar measurements |d 2011transfer abstract |g Amsterdam [u.a.] |w (DE-627)ELV026173794 |
773 | 1 | 8 | |g volume:25 |g year:2019 |g number:3 |g pages:171-184 |g extent:14 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.molmed.2018.12.010 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_252 | ||
936 | b | k | |a 51.00 |j Werkstoffkunde: Allgemeines |q VZ |
951 | |a AR | ||
952 | |d 25 |j 2019 |e 3 |h 171-184 |g 14 |
author_variant |
e c o ec eco |
---|---|
matchkey_str |
obrieneincmcloughlinrachelm:2019----:osdrntelentvsonxgnrtoatsahlccua |
hierarchy_sort_str |
2019transfer abstract |
bklnumber |
51.00 |
publishDate |
2019 |
allfields |
10.1016/j.molmed.2018.12.010 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000896.pica (DE-627)ELV045954380 (ELSEVIER)S1471-4914(19)30002-4 DE-627 ger DE-627 rakwb eng 050 VZ 550 VZ 660 VZ 660 VZ 530 600 670 VZ 51.00 bkl O’Brien, Eóin C. verfasserin aut Considering the ‘Alternatives’ for Next-Generation Anti-Staphylococcus aureus Vaccine Development 2019transfer abstract 14 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Staphylococcus aureus is an opportunistic pathogen, which can readily develop antibiotic resistance and result in severe disease. To combat antibiotic resistance, new treatment strategies are being developed with a particular focus on vaccine development. S. aureus vaccines that target humoral immunity alone do not provide sufficient protection from all disease phenotypes associated with this pathogen. Recent studies have identified the requirement for cellular immunity to provide a robust immune response to this infection. Driving conventional T cell responses has therefore become the focus of intense research in this area. Recently described ‘alternative’ T cells could provide a novel strategy for improving therapeutic efficacy and success in next-generation anti-S. aureus vaccine design. Staphylococcus aureus is an opportunistic pathogen, which can readily develop antibiotic resistance and result in severe disease. To combat antibiotic resistance, new treatment strategies are being developed with a particular focus on vaccine development. S. aureus vaccines that target humoral immunity alone do not provide sufficient protection from all disease phenotypes associated with this pathogen. Recent studies have identified the requirement for cellular immunity to provide a robust immune response to this infection. Driving conventional T cell responses has therefore become the focus of intense research in this area. Recently described ‘alternative’ T cells could provide a novel strategy for improving therapeutic efficacy and success in next-generation anti-S. aureus vaccine design. MAIT cells Elsevier γδ cells Elsevier innate lymphoid cells Elsevier Staphylococcus aureus Elsevier McLoughlin, Rachel M. oth Enthalten in Elsevier Science Ocean sand ridge signatures in the Bohai Sea observed by satellite ocean color and synthetic aperture radar measurements 2011transfer abstract Amsterdam [u.a.] (DE-627)ELV026173794 volume:25 year:2019 number:3 pages:171-184 extent:14 https://doi.org/10.1016/j.molmed.2018.12.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_73 GBV_ILN_252 51.00 Werkstoffkunde: Allgemeines VZ AR 25 2019 3 171-184 14 |
spelling |
10.1016/j.molmed.2018.12.010 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000896.pica (DE-627)ELV045954380 (ELSEVIER)S1471-4914(19)30002-4 DE-627 ger DE-627 rakwb eng 050 VZ 550 VZ 660 VZ 660 VZ 530 600 670 VZ 51.00 bkl O’Brien, Eóin C. verfasserin aut Considering the ‘Alternatives’ for Next-Generation Anti-Staphylococcus aureus Vaccine Development 2019transfer abstract 14 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Staphylococcus aureus is an opportunistic pathogen, which can readily develop antibiotic resistance and result in severe disease. To combat antibiotic resistance, new treatment strategies are being developed with a particular focus on vaccine development. S. aureus vaccines that target humoral immunity alone do not provide sufficient protection from all disease phenotypes associated with this pathogen. Recent studies have identified the requirement for cellular immunity to provide a robust immune response to this infection. Driving conventional T cell responses has therefore become the focus of intense research in this area. Recently described ‘alternative’ T cells could provide a novel strategy for improving therapeutic efficacy and success in next-generation anti-S. aureus vaccine design. Staphylococcus aureus is an opportunistic pathogen, which can readily develop antibiotic resistance and result in severe disease. To combat antibiotic resistance, new treatment strategies are being developed with a particular focus on vaccine development. S. aureus vaccines that target humoral immunity alone do not provide sufficient protection from all disease phenotypes associated with this pathogen. Recent studies have identified the requirement for cellular immunity to provide a robust immune response to this infection. Driving conventional T cell responses has therefore become the focus of intense research in this area. Recently described ‘alternative’ T cells could provide a novel strategy for improving therapeutic efficacy and success in next-generation anti-S. aureus vaccine design. MAIT cells Elsevier γδ cells Elsevier innate lymphoid cells Elsevier Staphylococcus aureus Elsevier McLoughlin, Rachel M. oth Enthalten in Elsevier Science Ocean sand ridge signatures in the Bohai Sea observed by satellite ocean color and synthetic aperture radar measurements 2011transfer abstract Amsterdam [u.a.] (DE-627)ELV026173794 volume:25 year:2019 number:3 pages:171-184 extent:14 https://doi.org/10.1016/j.molmed.2018.12.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_73 GBV_ILN_252 51.00 Werkstoffkunde: Allgemeines VZ AR 25 2019 3 171-184 14 |
allfields_unstemmed |
10.1016/j.molmed.2018.12.010 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000896.pica (DE-627)ELV045954380 (ELSEVIER)S1471-4914(19)30002-4 DE-627 ger DE-627 rakwb eng 050 VZ 550 VZ 660 VZ 660 VZ 530 600 670 VZ 51.00 bkl O’Brien, Eóin C. verfasserin aut Considering the ‘Alternatives’ for Next-Generation Anti-Staphylococcus aureus Vaccine Development 2019transfer abstract 14 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Staphylococcus aureus is an opportunistic pathogen, which can readily develop antibiotic resistance and result in severe disease. To combat antibiotic resistance, new treatment strategies are being developed with a particular focus on vaccine development. S. aureus vaccines that target humoral immunity alone do not provide sufficient protection from all disease phenotypes associated with this pathogen. Recent studies have identified the requirement for cellular immunity to provide a robust immune response to this infection. Driving conventional T cell responses has therefore become the focus of intense research in this area. Recently described ‘alternative’ T cells could provide a novel strategy for improving therapeutic efficacy and success in next-generation anti-S. aureus vaccine design. Staphylococcus aureus is an opportunistic pathogen, which can readily develop antibiotic resistance and result in severe disease. To combat antibiotic resistance, new treatment strategies are being developed with a particular focus on vaccine development. S. aureus vaccines that target humoral immunity alone do not provide sufficient protection from all disease phenotypes associated with this pathogen. Recent studies have identified the requirement for cellular immunity to provide a robust immune response to this infection. Driving conventional T cell responses has therefore become the focus of intense research in this area. Recently described ‘alternative’ T cells could provide a novel strategy for improving therapeutic efficacy and success in next-generation anti-S. aureus vaccine design. MAIT cells Elsevier γδ cells Elsevier innate lymphoid cells Elsevier Staphylococcus aureus Elsevier McLoughlin, Rachel M. oth Enthalten in Elsevier Science Ocean sand ridge signatures in the Bohai Sea observed by satellite ocean color and synthetic aperture radar measurements 2011transfer abstract Amsterdam [u.a.] (DE-627)ELV026173794 volume:25 year:2019 number:3 pages:171-184 extent:14 https://doi.org/10.1016/j.molmed.2018.12.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_73 GBV_ILN_252 51.00 Werkstoffkunde: Allgemeines VZ AR 25 2019 3 171-184 14 |
allfieldsGer |
10.1016/j.molmed.2018.12.010 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000896.pica (DE-627)ELV045954380 (ELSEVIER)S1471-4914(19)30002-4 DE-627 ger DE-627 rakwb eng 050 VZ 550 VZ 660 VZ 660 VZ 530 600 670 VZ 51.00 bkl O’Brien, Eóin C. verfasserin aut Considering the ‘Alternatives’ for Next-Generation Anti-Staphylococcus aureus Vaccine Development 2019transfer abstract 14 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Staphylococcus aureus is an opportunistic pathogen, which can readily develop antibiotic resistance and result in severe disease. To combat antibiotic resistance, new treatment strategies are being developed with a particular focus on vaccine development. S. aureus vaccines that target humoral immunity alone do not provide sufficient protection from all disease phenotypes associated with this pathogen. Recent studies have identified the requirement for cellular immunity to provide a robust immune response to this infection. Driving conventional T cell responses has therefore become the focus of intense research in this area. Recently described ‘alternative’ T cells could provide a novel strategy for improving therapeutic efficacy and success in next-generation anti-S. aureus vaccine design. Staphylococcus aureus is an opportunistic pathogen, which can readily develop antibiotic resistance and result in severe disease. To combat antibiotic resistance, new treatment strategies are being developed with a particular focus on vaccine development. S. aureus vaccines that target humoral immunity alone do not provide sufficient protection from all disease phenotypes associated with this pathogen. Recent studies have identified the requirement for cellular immunity to provide a robust immune response to this infection. Driving conventional T cell responses has therefore become the focus of intense research in this area. Recently described ‘alternative’ T cells could provide a novel strategy for improving therapeutic efficacy and success in next-generation anti-S. aureus vaccine design. MAIT cells Elsevier γδ cells Elsevier innate lymphoid cells Elsevier Staphylococcus aureus Elsevier McLoughlin, Rachel M. oth Enthalten in Elsevier Science Ocean sand ridge signatures in the Bohai Sea observed by satellite ocean color and synthetic aperture radar measurements 2011transfer abstract Amsterdam [u.a.] (DE-627)ELV026173794 volume:25 year:2019 number:3 pages:171-184 extent:14 https://doi.org/10.1016/j.molmed.2018.12.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_73 GBV_ILN_252 51.00 Werkstoffkunde: Allgemeines VZ AR 25 2019 3 171-184 14 |
allfieldsSound |
10.1016/j.molmed.2018.12.010 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000896.pica (DE-627)ELV045954380 (ELSEVIER)S1471-4914(19)30002-4 DE-627 ger DE-627 rakwb eng 050 VZ 550 VZ 660 VZ 660 VZ 530 600 670 VZ 51.00 bkl O’Brien, Eóin C. verfasserin aut Considering the ‘Alternatives’ for Next-Generation Anti-Staphylococcus aureus Vaccine Development 2019transfer abstract 14 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Staphylococcus aureus is an opportunistic pathogen, which can readily develop antibiotic resistance and result in severe disease. To combat antibiotic resistance, new treatment strategies are being developed with a particular focus on vaccine development. S. aureus vaccines that target humoral immunity alone do not provide sufficient protection from all disease phenotypes associated with this pathogen. Recent studies have identified the requirement for cellular immunity to provide a robust immune response to this infection. Driving conventional T cell responses has therefore become the focus of intense research in this area. Recently described ‘alternative’ T cells could provide a novel strategy for improving therapeutic efficacy and success in next-generation anti-S. aureus vaccine design. Staphylococcus aureus is an opportunistic pathogen, which can readily develop antibiotic resistance and result in severe disease. To combat antibiotic resistance, new treatment strategies are being developed with a particular focus on vaccine development. S. aureus vaccines that target humoral immunity alone do not provide sufficient protection from all disease phenotypes associated with this pathogen. Recent studies have identified the requirement for cellular immunity to provide a robust immune response to this infection. Driving conventional T cell responses has therefore become the focus of intense research in this area. Recently described ‘alternative’ T cells could provide a novel strategy for improving therapeutic efficacy and success in next-generation anti-S. aureus vaccine design. MAIT cells Elsevier γδ cells Elsevier innate lymphoid cells Elsevier Staphylococcus aureus Elsevier McLoughlin, Rachel M. oth Enthalten in Elsevier Science Ocean sand ridge signatures in the Bohai Sea observed by satellite ocean color and synthetic aperture radar measurements 2011transfer abstract Amsterdam [u.a.] (DE-627)ELV026173794 volume:25 year:2019 number:3 pages:171-184 extent:14 https://doi.org/10.1016/j.molmed.2018.12.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_73 GBV_ILN_252 51.00 Werkstoffkunde: Allgemeines VZ AR 25 2019 3 171-184 14 |
language |
English |
source |
Enthalten in Ocean sand ridge signatures in the Bohai Sea observed by satellite ocean color and synthetic aperture radar measurements Amsterdam [u.a.] volume:25 year:2019 number:3 pages:171-184 extent:14 |
sourceStr |
Enthalten in Ocean sand ridge signatures in the Bohai Sea observed by satellite ocean color and synthetic aperture radar measurements Amsterdam [u.a.] volume:25 year:2019 number:3 pages:171-184 extent:14 |
format_phy_str_mv |
Article |
bklname |
Werkstoffkunde: Allgemeines |
institution |
findex.gbv.de |
topic_facet |
MAIT cells γδ cells innate lymphoid cells Staphylococcus aureus |
dewey-raw |
050 |
isfreeaccess_bool |
false |
container_title |
Ocean sand ridge signatures in the Bohai Sea observed by satellite ocean color and synthetic aperture radar measurements |
authorswithroles_txt_mv |
O’Brien, Eóin C. @@aut@@ McLoughlin, Rachel M. @@oth@@ |
publishDateDaySort_date |
2019-01-01T00:00:00Z |
hierarchy_top_id |
ELV026173794 |
dewey-sort |
250 |
id |
ELV045954380 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV045954380</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230626012736.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191021s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.molmed.2018.12.010</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000896.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV045954380</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1471-4914(19)30002-4</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">050</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">550</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">660</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">660</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">530</subfield><subfield code="a">600</subfield><subfield code="a">670</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">51.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">O’Brien, Eóin C.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Considering the ‘Alternatives’ for Next-Generation Anti-Staphylococcus aureus Vaccine Development</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">14</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Staphylococcus aureus is an opportunistic pathogen, which can readily develop antibiotic resistance and result in severe disease. To combat antibiotic resistance, new treatment strategies are being developed with a particular focus on vaccine development. S. aureus vaccines that target humoral immunity alone do not provide sufficient protection from all disease phenotypes associated with this pathogen. Recent studies have identified the requirement for cellular immunity to provide a robust immune response to this infection. Driving conventional T cell responses has therefore become the focus of intense research in this area. Recently described ‘alternative’ T cells could provide a novel strategy for improving therapeutic efficacy and success in next-generation anti-S. aureus vaccine design.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Staphylococcus aureus is an opportunistic pathogen, which can readily develop antibiotic resistance and result in severe disease. To combat antibiotic resistance, new treatment strategies are being developed with a particular focus on vaccine development. S. aureus vaccines that target humoral immunity alone do not provide sufficient protection from all disease phenotypes associated with this pathogen. Recent studies have identified the requirement for cellular immunity to provide a robust immune response to this infection. Driving conventional T cell responses has therefore become the focus of intense research in this area. Recently described ‘alternative’ T cells could provide a novel strategy for improving therapeutic efficacy and success in next-generation anti-S. aureus vaccine design.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MAIT cells</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">γδ cells</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">innate lymphoid cells</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Staphylococcus aureus</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">McLoughlin, Rachel M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="t">Ocean sand ridge signatures in the Bohai Sea observed by satellite ocean color and synthetic aperture radar measurements</subfield><subfield code="d">2011transfer abstract</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV026173794</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:25</subfield><subfield code="g">year:2019</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:171-184</subfield><subfield code="g">extent:14</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.molmed.2018.12.010</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_252</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">51.00</subfield><subfield code="j">Werkstoffkunde: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">25</subfield><subfield code="j">2019</subfield><subfield code="e">3</subfield><subfield code="h">171-184</subfield><subfield code="g">14</subfield></datafield></record></collection>
|
author |
O’Brien, Eóin C. |
spellingShingle |
O’Brien, Eóin C. ddc 050 ddc 550 ddc 660 ddc 530 bkl 51.00 Elsevier MAIT cells Elsevier γδ cells Elsevier innate lymphoid cells Elsevier Staphylococcus aureus Considering the ‘Alternatives’ for Next-Generation Anti-Staphylococcus aureus Vaccine Development |
authorStr |
O’Brien, Eóin C. |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV026173794 |
format |
electronic Article |
dewey-ones |
050 - General serial publications 550 - Earth sciences 660 - Chemical engineering 530 - Physics 600 - Technology 670 - Manufacturing |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
050 VZ 550 VZ 660 VZ 530 600 670 VZ 51.00 bkl Considering the ‘Alternatives’ for Next-Generation Anti-Staphylococcus aureus Vaccine Development MAIT cells Elsevier γδ cells Elsevier innate lymphoid cells Elsevier Staphylococcus aureus Elsevier |
topic |
ddc 050 ddc 550 ddc 660 ddc 530 bkl 51.00 Elsevier MAIT cells Elsevier γδ cells Elsevier innate lymphoid cells Elsevier Staphylococcus aureus |
topic_unstemmed |
ddc 050 ddc 550 ddc 660 ddc 530 bkl 51.00 Elsevier MAIT cells Elsevier γδ cells Elsevier innate lymphoid cells Elsevier Staphylococcus aureus |
topic_browse |
ddc 050 ddc 550 ddc 660 ddc 530 bkl 51.00 Elsevier MAIT cells Elsevier γδ cells Elsevier innate lymphoid cells Elsevier Staphylococcus aureus |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
r m m rm rmm |
hierarchy_parent_title |
Ocean sand ridge signatures in the Bohai Sea observed by satellite ocean color and synthetic aperture radar measurements |
hierarchy_parent_id |
ELV026173794 |
dewey-tens |
050 - Magazines, journals & serials 550 - Earth sciences & geology 660 - Chemical engineering 530 - Physics 600 - Technology 670 - Manufacturing |
hierarchy_top_title |
Ocean sand ridge signatures in the Bohai Sea observed by satellite ocean color and synthetic aperture radar measurements |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV026173794 |
title |
Considering the ‘Alternatives’ for Next-Generation Anti-Staphylococcus aureus Vaccine Development |
ctrlnum |
(DE-627)ELV045954380 (ELSEVIER)S1471-4914(19)30002-4 |
title_full |
Considering the ‘Alternatives’ for Next-Generation Anti-Staphylococcus aureus Vaccine Development |
author_sort |
O’Brien, Eóin C. |
journal |
Ocean sand ridge signatures in the Bohai Sea observed by satellite ocean color and synthetic aperture radar measurements |
journalStr |
Ocean sand ridge signatures in the Bohai Sea observed by satellite ocean color and synthetic aperture radar measurements |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
000 - Computer science, information & general works 500 - Science 600 - Technology |
recordtype |
marc |
publishDateSort |
2019 |
contenttype_str_mv |
zzz |
container_start_page |
171 |
author_browse |
O’Brien, Eóin C. |
container_volume |
25 |
physical |
14 |
class |
050 VZ 550 VZ 660 VZ 530 600 670 VZ 51.00 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
O’Brien, Eóin C. |
doi_str_mv |
10.1016/j.molmed.2018.12.010 |
dewey-full |
050 550 660 530 600 670 |
title_sort |
considering the ‘alternatives’ for next-generation anti-staphylococcus aureus vaccine development |
title_auth |
Considering the ‘Alternatives’ for Next-Generation Anti-Staphylococcus aureus Vaccine Development |
abstract |
Staphylococcus aureus is an opportunistic pathogen, which can readily develop antibiotic resistance and result in severe disease. To combat antibiotic resistance, new treatment strategies are being developed with a particular focus on vaccine development. S. aureus vaccines that target humoral immunity alone do not provide sufficient protection from all disease phenotypes associated with this pathogen. Recent studies have identified the requirement for cellular immunity to provide a robust immune response to this infection. Driving conventional T cell responses has therefore become the focus of intense research in this area. Recently described ‘alternative’ T cells could provide a novel strategy for improving therapeutic efficacy and success in next-generation anti-S. aureus vaccine design. |
abstractGer |
Staphylococcus aureus is an opportunistic pathogen, which can readily develop antibiotic resistance and result in severe disease. To combat antibiotic resistance, new treatment strategies are being developed with a particular focus on vaccine development. S. aureus vaccines that target humoral immunity alone do not provide sufficient protection from all disease phenotypes associated with this pathogen. Recent studies have identified the requirement for cellular immunity to provide a robust immune response to this infection. Driving conventional T cell responses has therefore become the focus of intense research in this area. Recently described ‘alternative’ T cells could provide a novel strategy for improving therapeutic efficacy and success in next-generation anti-S. aureus vaccine design. |
abstract_unstemmed |
Staphylococcus aureus is an opportunistic pathogen, which can readily develop antibiotic resistance and result in severe disease. To combat antibiotic resistance, new treatment strategies are being developed with a particular focus on vaccine development. S. aureus vaccines that target humoral immunity alone do not provide sufficient protection from all disease phenotypes associated with this pathogen. Recent studies have identified the requirement for cellular immunity to provide a robust immune response to this infection. Driving conventional T cell responses has therefore become the focus of intense research in this area. Recently described ‘alternative’ T cells could provide a novel strategy for improving therapeutic efficacy and success in next-generation anti-S. aureus vaccine design. |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_73 GBV_ILN_252 |
container_issue |
3 |
title_short |
Considering the ‘Alternatives’ for Next-Generation Anti-Staphylococcus aureus Vaccine Development |
url |
https://doi.org/10.1016/j.molmed.2018.12.010 |
remote_bool |
true |
author2 |
McLoughlin, Rachel M. |
author2Str |
McLoughlin, Rachel M. |
ppnlink |
ELV026173794 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth |
doi_str |
10.1016/j.molmed.2018.12.010 |
up_date |
2024-07-06T18:56:05.686Z |
_version_ |
1803857077927411712 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV045954380</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230626012736.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191021s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.molmed.2018.12.010</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000896.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV045954380</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1471-4914(19)30002-4</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">050</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">550</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">660</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">660</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">530</subfield><subfield code="a">600</subfield><subfield code="a">670</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">51.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">O’Brien, Eóin C.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Considering the ‘Alternatives’ for Next-Generation Anti-Staphylococcus aureus Vaccine Development</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">14</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Staphylococcus aureus is an opportunistic pathogen, which can readily develop antibiotic resistance and result in severe disease. To combat antibiotic resistance, new treatment strategies are being developed with a particular focus on vaccine development. S. aureus vaccines that target humoral immunity alone do not provide sufficient protection from all disease phenotypes associated with this pathogen. Recent studies have identified the requirement for cellular immunity to provide a robust immune response to this infection. Driving conventional T cell responses has therefore become the focus of intense research in this area. Recently described ‘alternative’ T cells could provide a novel strategy for improving therapeutic efficacy and success in next-generation anti-S. aureus vaccine design.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Staphylococcus aureus is an opportunistic pathogen, which can readily develop antibiotic resistance and result in severe disease. To combat antibiotic resistance, new treatment strategies are being developed with a particular focus on vaccine development. S. aureus vaccines that target humoral immunity alone do not provide sufficient protection from all disease phenotypes associated with this pathogen. Recent studies have identified the requirement for cellular immunity to provide a robust immune response to this infection. Driving conventional T cell responses has therefore become the focus of intense research in this area. Recently described ‘alternative’ T cells could provide a novel strategy for improving therapeutic efficacy and success in next-generation anti-S. aureus vaccine design.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MAIT cells</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">γδ cells</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">innate lymphoid cells</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Staphylococcus aureus</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">McLoughlin, Rachel M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="t">Ocean sand ridge signatures in the Bohai Sea observed by satellite ocean color and synthetic aperture radar measurements</subfield><subfield code="d">2011transfer abstract</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV026173794</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:25</subfield><subfield code="g">year:2019</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:171-184</subfield><subfield code="g">extent:14</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.molmed.2018.12.010</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_252</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">51.00</subfield><subfield code="j">Werkstoffkunde: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">25</subfield><subfield code="j">2019</subfield><subfield code="e">3</subfield><subfield code="h">171-184</subfield><subfield code="g">14</subfield></datafield></record></collection>
|
score |
7.4010296 |